drugset / Trial / NCT03331900
Study of COR388 HCl in Healthy Subjects
RandomizedSequentialDouble-blindOther
Summary
The study is a randomized, double-blind, placebo-controlled, dose escalation, first-in-human trial of the safety and tolerability of COR388 HCl in healthy male and female subjects.
Timeline
- Start
- 2017-12-11
- Primary completion
- 2018-02-20
- Completion
- 2018-04-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ATUZAGINSTAT | Small molecule | — | Oral |
Indications
No indication recorded.